Published in Hum Immunol on September 01, 1993
Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors. Proc Natl Acad Sci U S A (1994) 1.29
PERB11 (MIC): a polymorphic MHC gene is expressed in skin and single nucleotide polymorphisms are associated with psoriasis. Clin Exp Immunol (2000) 0.76
Mosaic organization of DNA nucleotides. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1994) 10.43
Long-range correlations in nucleotide sequences. Nature (1992) 8.93
Nomenclature for the major histocompatibility complexes of different species: a proposal. Immunogenetics (1990) 3.53
Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 3.50
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest (2001) 3.22
Statement on the nomenclature of human C4 allotypes. Immunobiology (1983) 2.66
Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med (1995) 2.29
Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression. N Engl J Med (1973) 2.25
Evidence implicating nonmuscle myosin in restenosis. Use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy. Circulation (1992) 2.20
Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res (2000) 2.06
Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation (2000) 2.05
Nomenclature for factors of the HLA system, 1990. Tissue Antigens (1991) 1.98
PR39, a peptide regulator of angiogenesis. Nat Med (2000) 1.90
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
Analysis of HL-A incompatibility in human renal transplants. Tissue Antigens (1971) 1.89
Disease associations with complotypes, supratypes and haplotypes. Immunol Rev (1983) 1.87
Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature (1990) 1.87
Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol (1996) 1.86
Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration. J Cell Physiol (2000) 1.82
Central MHC genes, IgA deficiency and autoimmune disease. Immunol Today (1990) 1.81
Real-life radiation burden to relatives of patients treated with iodine-131: a study in eight centres in Flanders (Belgium). Eur J Nucl Med (1998) 1.79
Long-range correlation properties of coding and noncoding DNA sequences: GenBank analysis. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1995) 1.78
VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol (1996) 1.75
Linguistic features of noncoding DNA sequences. Phys Rev Lett (1994) 1.75
Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest (1993) 1.73
Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickening. Circulation (1997) 1.72
The P5 multicopy gene family in the MHC is related in sequence to human endogenous retroviruses HERV-L and HERV-16. Immunogenetics (1999) 1.71
Tomato seed and root exudate sugars: composition, utilization by Pseudomonas biocontrol strains and role in rhizosphere colonization. Environ Microbiol (1999) 1.67
Experimental myositis associated with hypersensitivity to muscle. J Pathol Bacteriol (1965) 1.59
Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity. J Biol Chem (2000) 1.58
Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system. Tissue Antigens (1992) 1.58
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun (2004) 1.53
HLA-D associated alloantisera react with molecules similar to Ia antigens. Proc Natl Acad Sci U S A (1977) 1.52
Fractal landscapes in biological systems: long-range correlations in DNA and interbeat heart intervals. Physica A (1992) 1.48
Ancestral haplotypes: conserved population MHC haplotypes. Hum Immunol (1992) 1.48
Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun (2005) 1.47
Angiogenesis in ischemic heart disease. Nat Med (1997) 1.46
Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma. Cancer Res (1999) 1.45
HLA haplotypes and susceptibility to rheumatoid arthritis. More than class II genes. Scand J Rheumatol (2002) 1.45
A comparison of iodine-123 meta-iodobenzylguanidine scintigraphy and single bone marrow aspiration biopsy in the diagnosis and follow-up of 26 children with neuroblastoma. Eur J Nucl Med (1993) 1.44
An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study). Am J Cardiol (2001) 1.43
Pericardial effusion in patients with cancer: outcome with contemporary management strategies. Heart (1996) 1.43
Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients. J Rheumatol (1997) 1.42
A deletion in the second exon of an HLA-DRB1 allele found in a DR2-negative narcolepsy patient. Hum Immunol (1993) 1.41
Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40
Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol (1993) 1.39
Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia. Clin Exp Immunol (1975) 1.38
An unexpected effect of matching for HLA-A9 in renal transplantation. Transplantation (1990) 1.38
Genetics of four new HL-A specificities in the Caucasian and Negro populations. Transplant Proc (1971) 1.38
Coronary vasoconstriction and catecholamine cardiomyopathy. Am Heart J (1985) 1.35
Generalized Lévy-walk model for DNA nucleotide sequences. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1993) 1.35
Laboratory tests in clinical immunology: a critique. Am J Med (1980) 1.34
Nomenclature for factors of the HLA system, 1995. Tissue Antigens (1995) 1.34
Autoimmunity in ocular and generalised myasthenia gravis. J Neuroimmunol (1981) 1.32
An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics (1992) 1.32
The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics (2000) 1.29
Antibodies to skeletal muscle demonstrated by immunofluorescence in experimental autoallergic myositis. Clin Exp Immunol (1971) 1.28
Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. J Invest Dermatol (2001) 1.28
Cloning, expression, and in vitro activity of human endostatin. Biochem Biophys Res Commun (1999) 1.28
Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide. J Clin Invest (2000) 1.27
Therapeutic angiogenesis in cardiology using protein formulations. Cardiovasc Res (2001) 1.26
Intracellular and secreted Alzheimer beta-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. Proc Natl Acad Sci U S A (1997) 1.26
The beta-amyloid domain is essential for axonal sorting of amyloid precursor protein. EMBO J (1996) 1.26
Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol (1995) 1.26
Complement allotyping in SLE: association with C4A null. Aust N Z J Med (1983) 1.24
SNP profile within the human major histocompatibility complex reveals an extreme and interrupted level of nucleotide diversity. Genome Res (2000) 1.24
Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes. Immunogenetics (1986) 1.23
Genetic control of suppressor lymphocyte function in myasthenia gravis: relationship of impaired suppressor function to HLA-B8/DRW3 and cold reactive lymphocytotoxic antibodies. Clin Immunol Immunopathol (1979) 1.23
Observer variation in grading sacroiliac radiographs in HLA-B27 positive individuals. J Rheumatol (1983) 1.23
Nomenclature for factors of the HLA system, 2000. Tissue Antigens (2001) 1.21
Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS (1992) 1.20
HLA and complement allotypes in Type 1 (insulin-dependent) diabetes. Diabetologia (1983) 1.20
Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am Heart J (2001) 1.20
Nomenclature for factors of the HLA system, 1994. Tissue Antigens (1994) 1.19
Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer. J Exp Med (2000) 1.19
Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes. J Exp Med (1993) 1.18
Phosphorylation of the cytoplasmic tail of syndecan-4 regulates activation of protein kinase Calpha. J Biol Chem (1998) 1.18
Nomenclature for factors of the HLA system, 1996. Tissue Antigens (1997) 1.18
Scaling features of noncoding DNA. Physica A (1999) 1.18
Immune function in ankylosing spondylitis: apparent relationship between streptococcal responses and HLA B27. J Rheumatol Suppl (1977) 1.17
Finite-size effects on long-range correlations: implications for analyzing DNA sequences. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1993) 1.17
A role for intestinal T lymphocytes in bronchus mucosal immunity. Immunology (1991) 1.16
Nomenclature for factors of the HLA system, 1995. Hum Immunol (1995) 1.16
Statistical properties of DNA sequences. Physica A (1995) 1.16
Systematic analysis of coding and noncoding DNA sequences using methods of statistical linguistics. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1995) 1.15
Macrophage-dependent regulation of syndecan gene expression. Circ Res (1997) 1.15
beta-Adrenergic receptors contribute to hypoxaemia induced vasodilation in man. Br J Clin Pharmacol (1995) 1.14
Biochemical complexity of serum HLA class I molecules. Immunogenetics (1988) 1.14
The "Sardinian" HLA-A30,B18,DR3,DQw2 haplotype constantly lacks the 21-OHA and C4B genes. Is it an ancestral haplotype without duplication? Immunogenetics (1989) 1.14
Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation (1999) 1.13
The role of syndecan cytoplasmic domain in basic fibroblast growth factor-dependent signal transduction. J Biol Chem (1999) 1.13
Extensive nucleotide variability within a 370 kb sequence from the central region of the major histocompatibility complex. Gene (1999) 1.12
Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics (1992) 1.11